NeuroOne Medical Technologies Corp NMTC
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2012-11-09 |
| Shares Out. | 8,700,000 |
| Website | nmtc1.com/ ↗ |
| Phone | 19524261383 |
| Employees | 18 |
| Revenue | $1.9M |
| Gross Profit | $990,264 |
| Net Income | -$2.4M |
| Free Cash Flow | -$7.6M |
| Total Assets | $7.6M |
| Total Liabilities | $2.5M |
| Equity | $5.1M |
About NeuroOne Medical Technologies Corp
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
NeuroOne Medical Technologies Corp is a publicly traded company under the ticker symbol NMTC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)